FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely - to otorhinolaryngology, neurology. The method involves larynx treatment. This is ensured by ultratone therapy with using the Ultratone-AMP-2INT apparatus. At first, the exposure covers a collar zone, and then - a larynx zone. Exposure duration is 5 to 10 minutes per each zone. The therapeutic course is 10-12 procedures. The ultratone therapy started is combined with oral administration of Mexidol 125 mg twice a day for 2-3 weeks.
EFFECT: method provides high clinical effectiveness of vocal rehabilitation following functional disorders due to normalising nervous larynx control, reduces prolongation of drug administration.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING CHRONIC EDEMATOUS POLYPOID LARYNGITIS IN EARLY POST-OPERATIVE PERIOD | 2011 |
|
RU2467774C1 |
METHOD OF BIOVIBROTHERAPY OF FUNCTIONAL PHONASTHENIA | 2007 |
|
RU2331403C1 |
METHOD OF TREATING HYPOTONIC DYSPHONIAS | 2010 |
|
RU2440812C1 |
METHOD FOR OBTAINING HYPO- AND HYPERTONIC FUNCTIONAL DYSPHONIA | 2001 |
|
RU2200530C2 |
METHOD FOR ADJUSTING FUNCTIONAL VOICE DISORDERS IN PATIENTS SUFFERING FROM PSYCHOEMOTIONAL DISORDERS | 2004 |
|
RU2273500C2 |
DIAGNOSTIC AND REHABILITATION METHOD OF THE PATIENTS WITH VOICE-SPEECH FUNCTION DISORDERS | 2020 |
|
RU2738660C1 |
METHOD FOR PREDICTING AND CORRECTING THE TREATMENT OF FUNCTIONAL PHONIC DISORDERS | 2005 |
|
RU2299009C2 |
METHOD OF TREATING POST-TRAUMATIC INJURIES OF LARYNX | 2009 |
|
RU2416396C1 |
METHOD FOR TREATING PATIENTS FOR LARYNGEAL MUSCLE PARESIS AND PARALYSIS | 2005 |
|
RU2290968C1 |
METHOD OF TREATING PATIENTS WITH STABLE FUNCTIONAL VOICE DISORDERS | 2014 |
|
RU2551218C1 |
Authors
Dates
2011-03-27—Published
2009-06-09—Filed